LXRX FY 2010 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$710M

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-54.1% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$96M-1950.2% margin

Net Income

-$102M-2073.7% margin

EPS (Diluted)

$-2.35

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$84M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$367M

Total Liabilities

$120M

Stockholders' Equity

$247M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$11M	-54.1%
Gross Profit	$5M	$11M	-54.1%
Operating Income	-$96M	-$90M	-6.4%
Net Income	-$102M	-$83M	-22.9%